Document is current
Any future updates will be listed below
-
Authors
Zhen, Sisi
Liu, Li
Zhang, Xiaoyu
Wang, Jieru
Sun, Jiali
Liang, Chen
Cao, Wenbin
Wei, Jialin
Zhai, Weihua
Chen, Xin
Ma, Qiaoling
Zhang, Rongli
Yang, Donglin https://orcid.org/0000-0002-8567-894X
He, Yi https://orcid.org/0000-0001-5726-3686
Pang, Aiming
Han, Mingzhe https://orcid.org/0000-0002-1720-6799
Jiang, Erlie https://orcid.org/0000-0003-0237-6063
Feng, Sizhou https://orcid.org/0000-0003-2768-6690
-
Funding
Funding for this research was provided by:
Chinese Academy of Medical Sciences (2023-I2M-2-007, 2021-I2M-1-017, 2021-I2M-1-060)
Natural Science Foundation of Tianjin Municipal Science and Technology Commission (21JCZDJC01170)
Chinese Society of Clinical Oncology
- License Information
-
More Information
Article History
Received: 11 March 2024
Revised: 31 January 2025
Accepted: 21 February 2025
First Online: 3 March 2025
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board and Ethics Committee of the Institute of Hematology and Blood Diseases Hospital. The ethics committee approved the waiver of informed consent owing to the retrospective nature of the review. All human data of patients’ records were confirmed for collection in accordance with the relevant guidelines and regulations.
: The authors declare no competing interests.
